HealthDay - TUESDAY, Aug. 8 (HealthDay News) -- Women whose mothers took DES, a synthetic estrogen, while pregnant have nearly double the risk of breast cancer.

A U.S. study says that women who took an anti-miscarriage drug during pregnancy doubled the risk of breast cancer for their daughters. An estimated 300,000 UK women starting the 1940s to the early 1970s took the drug Diethylstilbestrol (DES)....

American Cancer Society - Summary: Women whose mothers took the drug DES during pregnancy may have a higher risk for breast cancer than women not exposed to the drug in utero. The new finding suggests these women should be especially vigilant about breast cancer screening, researchers at Boston University School of Public Health say. Their work appears in the journal Cancer Epidemiology, Biomarkers, and Prevention.

A research study suggests that a blood test could detect the earliest stage of breast cancer. Among a study of 345 women, the test found 95% of cancers.

Reuters - Approximately 40 percent of women say they "feel uncomfortable" when asked to decide between breast-conserving surgery and radical mastectomy for breast cancer, according to a Canadian study.

Researchers report chest X-rays can significantly increase breast cancer risk in women with BRCA mutations. The investigators found out that it was correlated with a 54 percent increase in the chances of breast cancer occurring....

Reuters - Researchers report that exposure to chest X-rays has a "relatively large effect" on breast cancer risk in women who are carriers of BRCA mutations, which increase their susceptibility to breast cancer.

British researchers find the drug anastrozole is tolerated better in postmenopausal women in the early stages of breast cancer than tamoxifen, after they've undergone surgery. The scientists followed more than 6,000 postmenopausal women with breast cancer that had not spread to other areas of the...

Reuters - Women getting over breast cancer treatment who engage in aerobic and resistance training exercises may have better physical fitness and better quality-of-life than their more sedentary counterparts, new study findings show.

HealthDay - THURSDAY, July 27 (HealthDay News) -- Breast cancer patients with breast implants have the option of breast conservation, rather than full mastectomy, a new study finds.

HealthDay - THURSDAY, July 27 (HealthDay News) -- Breast cancer patients with breast implants have the option of breast conservation, rather than full mastectomy, a new study finds.

Clinical advice for the breast cancer drug Herceptin was questioned by a local health group. They cited vague information regarding patient treatment, cost effectiveness and potential risks.

Reuters - Women may often lack information about breast cancer on their father's side of the family, a problem that could cloud their view of their own risk, new research suggests.

AP - Older women who take hormone pills that combine estrogen and testosterone more than double their risk of breast cancer, according to a study of more than 70,000 nurses.

U.S. researchers stated on Monday that Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives. Researchers report that women at the highest risk of breast cancer do appear to be living longer if they take Tamoxifen....

U.S. researchers stated on Monday that Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives. Researchers report that women at the highest risk of breast cancer do appear to be living longer if they take Tamoxifen....

AP - Older women who take hormone pills that combine estrogen and testosterone more than double their risk of breast cancer, according to a study of more than 70,000 nurses.

Reuters - Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives, U.S. researchers reported on Monday.

Researchers worry that if the 10,000 women surveyed worldwide know little about the risk factors for breast cancer than everyone else probably knows about the same or less. Cancer Research UK lead the study and surveyed university students in 23 countries. However they found that many of those...

Reuters - A cluster of characteristics that include high cholesterol, obesity, high blood sugar and high blood pressure -- dubbed metabolic syndrome -- has been linked previously to the development of diabetes and heart disease. Now, Italian researchers say it is "an important prognostic factor" in the recurrence of breast cancer.